New Resource to Educate Consumers About Blepharitis, Demodex and Other Lid Margin Diseases


We are pleased to announce our newly revamped Cliradex.com website to help educate patients and build awareness about eye health and wellness, particularly related to blepharitis, Demodex, dry eye, ocular rosacea and other lid margin diseases.

The website also provides you and your staff access to clinical and product information about Cliradex, our preservative-free, all-natural lid, lash, and facial cleanser. Cliradex isolates 4-Terpineol, the most important ingredient in tea tree oil, that is clinically-proven to safely and effectively clean the skin and eradicate Demodex mites.

Blepharitis – Signs and Symptoms, Treatments and Practice Management


In part two of his two part series, Dr. Schachter discusses the signs and symptoms of blepharitis, treatments, and practice management. View part one, Blepharitis - Overview and Prevalence.

Blepharitis, like many ocular surface diseases, is a condition where signs and symptoms don't always match. Therefore, it is often overlooked. The reason for this may be that blepharitis is a chronic, progressive condition. In our practice, we screen for the disease and treat it early. If you let it progress it will be harder to treat.

Lid Wipes or Lid Scrubs?


When treating ocular surface diseases such as dry eye, blepharitis, meibomian gland dysfunction, and Demodex, there are various approaches and treatment options based on the patient’s condition. Many of these approaches such as lid scrubs and lid wipes not only treat the condition, but also help to prevent it from worsening by adhering to good lid hygiene. However, it is important to understand the differences between the two and when/for what condition each should be used.

Blepharitis – Overview and Prevalence


In part one of a two part series, Dr. Schachter discusses the prevalence of blepharitis and the opportunity this presents for eyecare providers.

Blepharitis, or eyelid inflammation, is a very common, chronic condition that presents in our practices every day. In the US, blepharitis affects approximately 80 million patients each year. In a study done in my practice, we found around 25 of 100 consecutive patients had blepharitis.